
Vaccine-maker’s Ottawa R&D efforts get boost thanks to millions in fresh funding
VBI Vaccines will immediately have access to up to $50 million (all terms U.S.) in cash, consisting of $30 million in refinanced funding as well
Vaccine-maker’s Ottawa R&D efforts get boost thanks to millions in fresh funding
VBI Vaccines will immediately have access to up to $50 million (all terms U.S.) in cash, consisting of $30 million in refinanced funding as well
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
Collecting judgments may not be as easy as you think
This is your chance to contribute to the revitalization of the ByWard Market!
Big Brothers Big Sisters of Ottawa